SRPT: Sarepta Therapeutics Inc. (DE) Stocks News on January 19, 2025

SRPT

Argus Research

4 days ago

SRPT: Lowering target price to $95.00

Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2024 Net Product Revenue

SRPT

Business Wire

5 days ago

Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2024 Net Product Revenue

SRPT

MT Newswires

11 days ago

RBC Cuts Price Target on Sarepta Therapeutics to $165 From $182, Keeps Outperform Rating

Sarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SRPT

Business Wire

12 days ago

Sarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SRPT

Zacks

12 days ago

SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell?

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Business Wire

18 days ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Insider Monkey

21 days ago

Sarepta Therapeutics, Inc. (SRPT): Is This Gene Therapy Stock a Good Buy Right Now?

Exploring High Growth Tech Stocks in the US December 2024

SRPT

Simply Wall St.

23 days ago

Exploring High Growth Tech Stocks in the US December 2024

SRPT

Argus Research

a month ago

SRPT: Lowering target price to $97.00

SRPT

Insider Monkey

a month ago

Is Sarepta Therapeutics, Inc. (SRPT) the Best Performing Biotech Stock in 2024?

SRPT

Zacks

a month ago

The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

SRPT

Zacks

a month ago

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

Sarepta completes subject dosing in Phase III LGMD2E/R4 therapy trial

SRPT

Clinical Trials Arena

a month ago

Sarepta completes subject dosing in Phase III LGMD2E/R4 therapy trial

SRPT

Zacks

a month ago

SRPT Finishes Enrolment in Late-Stage Study for Rare Muscular Disorder

Sarepta Therapeutics Completes Enrollment in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4

SRPT

Business Wire

a month ago

Sarepta Therapeutics Completes Enrollment in EMERGENE, a Phase 3 Clinical Study of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E/R4

Tessera gets sickle cell funding; Corvus shares slide on eczema data

SRPT

BioPharma Dive

a month ago

Tessera gets sickle cell funding; Corvus shares slide on eczema data

SRPT

Argus Research

a month ago

SRPT: What does Argus have to say about SRPT?

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

SRPT

Zacks

a month ago

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

SRPT

MT Newswires

a month ago

Sarepta Therapeutics Insider Sold Shares Worth $1,310,820, According to a Recent SEC Filing

SRPT

Insider Monkey

a month ago

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

SRPT

Zacks

a month ago

Wall Street Analysts See a 47.95% Upside in Sarepta Therapeutics (SRPT): Can the Stock Really Move This High?

SRPT

Argus Research

a month ago

SRPT: What does Argus have to say about SRPT?

SRPT

Zacks

a month ago

Why Is Sarepta Therapeutics (SRPT) Up 4.9% Since Last Earnings Report?

SRPT

Argus Research

2 months ago

SRPT: Lowering target price to $101.00

SRPT

Zacks Small Cap Research

2 months ago

ARWR: License and Collaboration Deal with Sarepta Includes $825 Million Upon Closing…

Arrowhead price target lowered to $24 from $27 at Bernstein

SRPT

TipRanks

2 months ago

Arrowhead price target lowered to $24 from $27 at Bernstein

SRPT

Business Wire

2 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?

SRPT

Zacks

2 months ago

Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?

Sarepta price target lowered to $202 from $205 at Needham

SRPT

TipRanks

2 months ago

Sarepta price target lowered to $202 from $205 at Needham

SRPT

Zacks

2 months ago

SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies

SRPT

Zacks

2 months ago

Wall Street Analysts Think Sarepta Therapeutics (SRPT) Could Surge 42.11%: Read This Before Placing a Bet

Sarepta to pay Arrowhead $500M + in licensing deal for siRNA-based treatments

SRPT

TipRanks

2 months ago

Sarepta to pay Arrowhead $500M + in licensing deal for siRNA-based treatments

Arrowhead to get $825M in Sarepta licensing pact, appoints Sarepta CEO to board

SRPT

TipRanks

2 months ago

Arrowhead to get $825M in Sarepta licensing pact, appoints Sarepta CEO to board

Sarepta rebuilds drug pipeline with Arrowhead deal

SRPT

BioPharma Dive

2 months ago

Sarepta rebuilds drug pipeline with Arrowhead deal

Arrowhead and Sarepta link for rare genetic disease treatments

SRPT

Pharmaceutical Technology

2 months ago

Arrowhead and Sarepta link for rare genetic disease treatments

SRPT

Argus Research

2 months ago

SRPT: Raising target price to $104.00

Arrowhead Pharma, Sarepta TX ink new gene therapy deal

SRPT

Yahoo Finance Video

2 months ago

Arrowhead Pharma, Sarepta TX ink new gene therapy deal

SRPT

MT Newswires

2 months ago

Sector Update: Health Care

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal

SRPT

Investor's Business Daily

2 months ago

Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal

Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta

SRPT

Investor's Business Daily

2 months ago

Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta

SRPT

MT Newswires

2 months ago

Arrowhead Pharma, Sarepta Therapeutics Sign Licensing, Partnership Deal for Clinical, Preclinical Programs

Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs

SRPT

Business Wire

2 months ago

Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs

High Growth Tech Stocks to Watch in November 2024

SRPT

Simply Wall St.

2 months ago

High Growth Tech Stocks to Watch in November 2024

SRPT

Insider Monkey

2 months ago

Sarepta Therapeutics, Inc. (SRPT): Among 12 High Growth Large Cap Stocks to Buy Now

SRPT

Simply Wall St.

2 months ago

Why Sarepta Therapeutics' (NASDAQ:SRPT) Earnings Are Weaker Than They Seem

SRPT

Argus Research

2 months ago

SRPT: Lowering target price to $91.00

Sarepta recent weakness brings buying opportunity, says JPMorgan

SRPT

TipRanks

2 months ago

Sarepta recent weakness brings buying opportunity, says JPMorgan

Sarepta price target lowered to $193 from $200 at Baird

SRPT

TipRanks

2 months ago

Sarepta price target lowered to $193 from $200 at Baird

SRPT

Zacks

2 months ago

SRPT Beats on Q3 Earnings & Sales, Discontinues PPMO-Based DMD Program

SRPT

MT Newswires

2 months ago

Cantor Fitzgerald Upgrades Sarepta Therapeutics to Overweight, $167 Price Target

Sarepta scraps a Duchenne drug as gene therapy sales rise

SRPT

BioPharma Dive

2 months ago

Sarepta scraps a Duchenne drug as gene therapy sales rise

SRPT

MT Newswires

2 months ago

Sarepta Therapeutics Q3 Adjusted Earnings, Revenue Rise

SRPT

Motley Fool

2 months ago

Sarepta Therapeutics (SRPT) Q3 2024 Earnings Call Transcript

SRPT

GuruFocus.com

2 months ago

Sarepta Therapeutics Inc (SRPT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

SRPT

Zacks

2 months ago

Sarepta Therapeutics (SRPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

SRPT

Associated Press Finance

2 months ago

Sarepta Therapeutics: Q3 Earnings Snapshot

Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments

SRPT

Business Wire

2 months ago

Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments

SRPT

Argus Research

2 months ago

SRPT: Lowering target price to $100.00

SRPT

Business Wire

3 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Insider Monkey

3 months ago

Sarepta Therapeutics, Inc. (SRPT): An Unstoppable Stock That Could Make You Richer

Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results

SRPT

Business Wire

3 months ago

Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results

Exploring High Growth Tech Stocks In United States October 2024

SRPT

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In United States October 2024

SRPT

MT Newswires

3 months ago

Jefferies Initiates Sarepta Therapeutics at Buy With $165 Price Target

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up

SRPT

Investor's Business Daily

3 months ago

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up

2 High-Flying Growth Stocks With Massive Upside Potential

SRPT

Motley Fool

3 months ago

2 High-Flying Growth Stocks With Massive Upside Potential

SRPT

Insider Monkey

3 months ago

Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Biotech Stock According to Hedge Funds?

SRPT

Argus Research

3 months ago

SRPT: Lowering target price to $96.00

SRPT

MT Newswires

3 months ago

RBC Lifts Price Target on Sarepta Therapeutics to $182 From $181, Keeps Outperform Rating

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

SRPT

Motley Fool

4 months ago

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

SRPT

Business Wire

4 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Insider Monkey

4 months ago

Is Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress

SRPT

Business Wire

4 months ago

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress

Exploring TeraWulf And Two Other High Growth Tech Stocks

SRPT

Simply Wall St.

4 months ago

Exploring TeraWulf And Two Other High Growth Tech Stocks

SRPT

Insider Monkey

4 months ago

Sarepta Therapeutics (SRPT): Soaring with Successful Therapies and Cash Flow Positivity

SRPT

Zacks

4 months ago

Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options

Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors

SRPT

Business Wire

4 months ago

Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors

SRPT

Insider Monkey

4 months ago

Sarepta Therapeutics, Inc. (SRPT): Among Hedge Funds’ Top Biotech Stock Picks

SRPT

Motley Fool

4 months ago

These 2 Biotech Stocks Are Set to Soar

SRPT

Insider Monkey

4 months ago

Sarepta Therapeutics, Inc. (SRPT): This Biotech Stock Should Be On Your Radar

SRPT

Zacks

4 months ago

Why Is Sarepta Therapeutics (SRPT) Down 1.9% Since Last Earnings Report?

Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year

SRPT

Business Wire

4 months ago

Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year

Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy

SRPT

Benzinga

4 months ago

Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy

SRPT

Business Wire

5 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DMD clinical studies evolve with emphasis on building designs around relevant endpoints

SRPT

Clinical Trials Arena

5 months ago

DMD clinical studies evolve with emphasis on building designs around relevant endpoints

Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

SRPT

Business Wire

5 months ago

Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

SRPT

Argus Research

5 months ago

SRPT: Raising target price to $113.00

High Growth Tech Stocks To Watch In August 2024

SRPT

Simply Wall St.

5 months ago

High Growth Tech Stocks To Watch In August 2024

SRPT

Argus Research

5 months ago

SRPT: Raising target price to $112.00

Heard Writers Pick Their Favorite and Least-Favorite Stocks

SRPT

The Wall Street Journal

5 months ago

Heard Writers Pick Their Favorite and Least-Favorite Stocks

SRPT

MT Newswires

5 months ago

Sarepta Therapeutics Insider Bought Shares Worth $4,955,728, According to a Recent SEC Filing

Bull Signal Flashing for Sarepta Therapeutics Stock

SRPT

Schaeffer's Investment Research

5 months ago

Bull Signal Flashing for Sarepta Therapeutics Stock

A $3 Million Gene-Therapy Maker at a Bargain Price

SRPT

The Wall Street Journal

5 months ago

A $3 Million Gene-Therapy Maker at a Bargain Price

SRPT

Simply Wall St.

5 months ago

Shareholders In Sarepta Therapeutics (NASDAQ:SRPT) Should Look Beyond Earnings For The Full Story

2 Biotech Stocks to Buy Hand Over Fist in August

SRPT

Motley Fool

5 months ago

2 Biotech Stocks to Buy Hand Over Fist in August

SRPT

Simply Wall St.

5 months ago

Some Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Analysts Just Made A Major Cut To Next Year's Estimates

How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics

SRPT

Investor's Business Daily

5 months ago

How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics

SRPT

MT Newswires

5 months ago

UBS Raises Sarepta Therapeutics Price Target to $188 From $173, Maintains Buy Rating

SRPT

Zacks

5 months ago

Down -10.33% in 4 Weeks, Here's Why You Should You Buy the Dip in Sarepta Therapeutics (SRPT)

SRPT

Simply Wall St.

5 months ago

Can Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Improve Its Returns?

SRPT

Thomson Reuters StreetEvents

5 months ago

Latest Sarepta Therapeutics Inc. (DE) (SRPT) News on January 19, 2025

Share on Social Networks: